Inventor · disambiguated record
Matthias Brock
Also filed as: BROCK MATTHIAS
4 granted patents·4 pending applications·0 citations·filing 2018–2024
55Inventor score
Technology areasC07K
Files withNumab Therapeutics AG8
Top patents by PatentIndex Score
8 records- 0170US2025066482A1Antibodies targeting pdl1 and methods of use thereofNumab Therapeutics AG·Filed 2024·Application pending·0 cites
- 0258US12077588B2Antibodies targeting PDL1 and methods of use thereofNumab Therapeutics AG·Filed 2018·Granted Sep 3, 2024·0 cites·28 claims
- 0353US12209133B2Antibodies targeting CD137 and methods of use thereofNumab Therapeutics AG·Filed 2019·Granted Jan 28, 2025·0 cites·25 claims
- 0451US12202911B2Multispecific antibody comprising CD137 binding domain and PDL1 binding domainNumab Therapeutics AG·Filed 2018·Granted Jan 21, 2025·0 cites·3 claims
- 0551US11578133B2Antibodies targeting CD137 and methods of use thereofNumab Therapeutics AG·Filed 2018·Granted Feb 14, 2023·0 cites·15 claims
- 0650US2024392003A1Multispecific antibodies having specificity for ror1 and cd3Numab Therapeutics AG·Filed 2022·Application pending·0 cites
- 0749US2023203162A1Multispecific antibodyNumab Therapeutics AG·Filed 2021·Application pending·0 cites
- 0844US2024084039A1Antibody variable domains and antibodies having decreased immunogenicityNumab Therapeutics AG·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias Brock files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →